Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 12/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | GSK3A | P49840 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23015674 | 0.86 | NR3C2 (0.55) | NR3C2L3MBTL1MAPK14 | |
| SCHEMBL6952630 | 0.85 | NR3C2 (0.52) | NR3C2L3MBTL1MAPK14 | |
| SCHEMBL29166048 | 0.85 | NR3C2 (0.52) | NR3C2MAPK14NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3544821 | 0.82 | GCK (0.53) | NR3C2 | |
| SCHEMBL6806625 | 0.82 | NR3C2 (0.49) | NR3C2MAPK14 | |
| SCHEMBL5908257 | 0.81 | NR3C2 (0.47) | NR3C2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29507273 | 0.81 | L3MBTL1 (0.52) | NR3C2L3MBTL1MAPK14AURKAGSK3A | |
| SCHEMBL501285 | 0.81 | L3MBTL1 (0.52) | NR3C2L3MBTL1MAPK14AURKAGSK3A | |
| SCHEMBL7671508 | 0.81 | L3MBTL1 (0.52) | NR3C2L3MBTL1MAPK14AURKAGSK3A | |
| SCHEMBL91333 | 0.81 | RIOK2 (0.57) | NR3C2L3MBTL1AURKAGSK3AGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674623-B1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-04-09 | — | — | EP | disclosed |
| US-6403578-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | disclosed |
| EP-0674623-A1 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-10-04 | — | — | EP | disclosed |
| WO-1994014776-A2 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-07-07 | — | — | WO | disclosed |